Girdlestone procedure: when and why

被引:33
|
作者
Cordero-Ampuero, Jose [1 ]
机构
[1] Univ Autonoma Madrid, Sch Med, Hosp Univ Princesa, Dept Orthopaed Surg, Madrid, Spain
关键词
Functional results; Girdlestone; Infected hip; PROSTHETIC JOINT INFECTION; RESECTION ARTHROPLASTY; ORAL ANTIBIOTICS; REIMPLANTATION; SUPERIOR; THERAPY;
D O I
10.5301/HIP.2012.9568
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Girdlestone is one of the options for treating an infected hip arthroplasty (along with isolated antibiotics, debridement, and one or two-stage exchange). The choice must be based on a list of previous considerations. Results of girdlestone: Major differences among different series are reported in literature: from 13% to 83% of patients are satisfied with the result. Healing of infection is attained in 80% to 100% of patients, but figures are worse in special subsets (rheumatoid arthritis, enterococcal and methicillin-resistant infections, or when cement is retained). Pain is reported as severe in 16% to 33% of patients, moderate in 24% to 53% and mild in 76%, while only some authors refer to "satisfactory pain relief". Up to 45% of geriatric patients are unable to walk and only 29% walk independently. The literature reports Harris Hip scores from 25 to 64. Indications for girdlestone: Absolute indications: non-ambulatory patients because of other problems or diseases, and impossible reimplantation (2nd-stage surgery) (unacceptable anaesthetic or surgical risk, technical difficulties, patient rejection). Relative indications: Dementia (risk of dislocation vs. severely reduced walking ability), immunocompromise (up to what degree of immune impairment do we accept to take the risk?), intravenous drug abuse (how can you prove it?)
引用
收藏
页码:S36 / S39
页数:4
相关论文
共 50 条
  • [41] Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why
    Graham, David Y.
    Moss, Steven F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (04) : 524 - 528
  • [42] Understanding Why and When Optical Coherence Tomography Does Not Detect Vulnerable Plaques Is It Important?
    Mintz, Gary S.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (07)
  • [43] Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how
    Calzetta, Luigino
    Matera, Maria Gabriella
    Rogliani, Paola
    Cazzola, Mario
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (04) : 261 - 264
  • [44] Surgical therapy of hip-joint empyema. Is the Girdlestone arthroplasty still up to date?
    Oheim, Ralf
    Gille, Justus
    Schoop, Rita
    Maegerlein, Sonja
    Grimme, Cornelius H.
    Juergens, Christian
    Gerlach, Ulf-Joachim
    INTERNATIONAL ORTHOPAEDICS, 2012, 36 (05) : 927 - 933
  • [45] A topical regimen improves skin healing and aesthetic outcomes when combined with a radiofrequency microneedling procedure
    Gold, Michael H.
    Sensing, Whitney
    Biron, Julie A.
    JOURNAL OF COSMETIC DERMATOLOGY, 2019, 18 (05) : 1280 - 1289
  • [46] The why, when, where, how, and so what of so-called rapidly acting antidepressants
    Schatzberg, Alan F.
    Mathew, Sanjay J.
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (01) : 189 - 196
  • [47] Multi-modal prehabilitation: addressing the why, when, what, how, who and where next?
    Scheede-Bergdahl, C.
    Minnella, E. M.
    Carli, F.
    ANAESTHESIA, 2019, 74 : 20 - 26
  • [48] When and Why to Use FDG PET/CT in Locally Advanced Rectal Cancer Two Scenarios
    Maffione, Anna Margherita
    Galeotti, Fabrizio
    Capirci, Carlo
    Colletti, Patrick M.
    Rubello, Domenico
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (06) : 528 - 530
  • [49] Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate
    Imran, Farhan
    Phatak, Pradyumna
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (01) : 53 - 64
  • [50] THE IMPLANT INFECTION PARADOX: WHY DO SOME SUCCEED WHEN OTHERS FAIL? OPINION AND DISCUSSION PAPER
    Yue, C.
    Zhao, B.
    Ren, Y.
    Kuijer, R.
    van der Mei, H. C.
    Busscher, H. J.
    Rochford, E. T. J.
    EUROPEAN CELLS & MATERIALS, 2015, 29 : 303 - 313